Dr. Michael D. Ioffreda, MD

Dr. Ioffreda practices at Institute for Dermatopathology, Inc. in Newtown Square, Pennsylvania.

Dr. Ioffreda's NPI, 1386607018, was assigned on April 12, 2006. Dr. Ioffreda graduated from Jefferson Medical College of Thomas Jefferson University in 1990. Dr. Ioffreda holds Pennsylvania license MD062143L.

Dr. Ioffreda's primary practice is Institute for Dermatopathology, Inc., at 3810 W Chester Park, Newtown Square, PA 19073 in Delaware County. The practice phone is (610) 260-0555.

Dr. Ioffreda's primary practice is Institute for Dermatopathology, Inc. in Newtown Square, Pennsylvania. Dr. Ioffreda is also affiliated with Penn State Health Milton S. Hershey Medical Center. The medical group on file is Penn State Health Milton S. Hershey Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ioffreda practices. Vendor and product names are available with a free account.

Dermatology is Dr. Ioffreda's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ioffreda is licensed in Pennsylvania.

CMS data shows 1,909 Medicare services from Dr. Ioffreda across 19 procedure codes in 2024, for 953 Medicare patients. Medicare paid $50,003 for them.

CMS counts 953 Medicare patients who saw Dr. Ioffreda in 2024. The largest group is 65 to 74, with 409 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ioffreda's median patient age at 73, with 51% women.

In 2024, Dr. Ioffreda wrote 172 Medicare Part D claims for 68 patients. 87% of them were for generic drugs. CMS names the drug for 70 of them, across 3 drugs with 11 or more claims each, at $2,279 in total drug cost. In 2023, CMS named 62 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Ioffreda for performance year 2024, reported as part of a group. Dr. Ioffreda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 205 procedures of removal of skin lesions by Dr. Ioffreda, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 15 papers to Dr. Ioffreda, published from 2014 to 2024. The most frequent topics are Biopsy, Scalp and Skin Neoplasms. Dr. Ioffreda has published most often in J Am Acad Dermatol. Dr. Ioffreda's most frequent co-authors are Klaus F. Helm, MD, Taha Al-Shaikhly, MBCHB and Sarah Alison Finger Basak, MD.

CMS Open Payments shows 1 general payment to Dr. Ioffreda from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $64.

Dr. Ioffreda graduated from Jefferson Medical College of Thomas Jefferson University in 1990.